Involvement of tumor necrosis factor-α receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation

被引:13
|
作者
Tashiro, H
Itamoto, T
Ohdan, H
Arihiro, K
Tateaki, Y
Nakahara, H
Ochi, M
Hino, H
Mizunuma, K
Hara, H
Tokita, D
Onoe, T
Ishiyama, K
Mitsuta, H
Sugino, K
Asahara, T
机构
[1] Hiroshima Univ, Fac Med, Dept Surg 2, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Pathol, Hiroshima, Japan
[3] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Dev Biol Lab, Hiroshima, Japan
关键词
ischemia; reperfusion injury; apoptosis; necrosis; liver allograft; death receptor;
D O I
10.1007/s00147-004-0762-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
The pathway leading to cell death in clinical liver transplantation is not known. Eight liver transplant recipients and eight donors were enrolled in this study. Postoperative serum levels of alanine transferase had significantly increased in the recipients compared with those in the donors. Mild centri-lobular necrosis was observed in only liver tissues taken from the recipients. Tumor necrosis factor (TNF)-R1 and death receptor 5 expression levels had increased in liver tissues taken from the recipients. There were no changes in the levels of Fas/Fas ligand expression in liver tissues from either the donors or recipients. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression was down-regulated in donor liver after hepatectomy and liver allograft after implantation. The results suggest that, although ischemic liver injury was not serious, due to the short ischemia time, TNF and TRAIL signals are associated with liver ischemic injury in live-donor liver transplantation but Fas signal is not.
引用
收藏
页码:626 / 633
页数:8
相关论文
共 50 条
  • [21] Tumor necrosis factor-related apoptosis-inducing ligand and cardiovascular disease
    Ebert, Thomas
    Fasshauer, Mathias
    ATHEROSCLEROSIS, 2011, 215 (02) : 279 - 280
  • [22] Viral transfer of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in gene therapy
    Wedrowska, Ewelina
    Wandtke, Tomasz
    Dyczek, Andrzej
    Wozniak, Joanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 1411 - 1422
  • [23] Roles of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in experimental autoimmune encephalomyelitis
    Chen, YH
    Hilliard, BA
    Wilmen, A
    FASEB JOURNAL, 2001, 15 (05): : A1210 - A1210
  • [24] Roles of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in experimental autoimmune encephalomyelitis
    Hilliard, B
    Wilmen, A
    Seidel, C
    Liu, TT
    Göke, R
    Chen, Y
    FASEB JOURNAL, 2000, 14 (06): : A1101 - A1101
  • [25] Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis
    Schoppet, M
    Sattler, AM
    Schaefer, JR
    Hofbauer, LC
    ATHEROSCLEROSIS, 2006, 184 (02) : 446 - 447
  • [26] Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
    Elmallah, Mohammed I. Y.
    Micheau, Olivier
    MARINE DRUGS, 2015, 13 (11) : 6884 - 6909
  • [27] Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution
    Kelley, RF
    Totpal, K
    Lindstrom, SH
    Mathieu, M
    Billeci, K
    DeForge, L
    Pai, R
    Hymowitz, SG
    Ashkenazi, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (03) : 2205 - 2212
  • [28] Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
    Takeda, K
    Hayakawa, Y
    Smyth, M
    Kayagaki, N
    Yamaguchi, N
    Kakuta, S
    Iwakura, Y
    Yagita, H
    Okumura, K
    NATURE MEDICINE, 2001, 7 (01) : 94 - 100
  • [29] Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
    Kazuyoshi Takeda
    Yoshihiro Hayakawa
    Mark J. Smyth
    Nobuhiko Kayagaki
    Noriko Yamaguchi
    Shigeru Kakuta
    Yoichiro Iwakura
    Hideo Yagita
    Ko Okumura
    Nature Medicine, 2001, 7 : 94 - 100
  • [30] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediates tumor immune evasion in cholangiocarcinoma.
    Loeuillard, Emilien
    Yang, Jingchun
    Dong, Haidong
    Gores, Gregory J.
    Ilyas, Sumera
    CANCER RESEARCH, 2021, 81 (13)